(1)
Efficacy Of Loralatinib After Combination With Alectinib Central Lung Disease In One Patient In Kinase-Positive Anaplastic Lymphoma Small Cell Lung Cancer: A Case Report. Clinical and Medical Case Reports 2022, 2 (01), 31-34.